- Home
- PRLD vs HYPR Comparison
PRLD vs HYPR Comparison
Compare PRLD & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- HYPR
- Stock Information
- Founded
- PRLD 2016
- HYPR 2014
- Country
- PRLD United States
- HYPR United States
- Employees
- PRLD N/A
- HYPR N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- HYPR Medical Specialities
- Sector
- PRLD Health Care
- HYPR Health Care
- Exchange
- PRLD Nasdaq
- HYPR Nasdaq
- Market Cap
- PRLD 50.1M
- HYPR 54.6M
- IPO Year
- PRLD 2020
- HYPR N/A
- Fundamental
- Price
- PRLD $0.89
- HYPR $0.60
- Analyst Decision
- PRLD Strong Buy
- HYPR Strong Buy
- Analyst Count
- PRLD 2
- HYPR 3
- Target Price
- PRLD $4.50
- HYPR $1.06
- AVG Volume (30 Days)
- PRLD 137.5K
- HYPR 559.8K
- Earning Date
- PRLD 05-06-2025
- HYPR 05-13-2025
- Dividend Yield
- PRLD N/A
- HYPR N/A
- EPS Growth
- PRLD N/A
- HYPR N/A
- EPS
- PRLD N/A
- HYPR N/A
- Revenue
- PRLD $7,000,000.00
- HYPR $11,732,000.00
- Revenue This Year
- PRLD N/A
- HYPR $13.22
- Revenue Next Year
- PRLD N/A
- HYPR $24.57
- P/E Ratio
- PRLD N/A
- HYPR N/A
- Revenue Growth
- PRLD N/A
- HYPR 0.34
- 52 Week Low
- PRLD $0.61
- HYPR $0.53
- 52 Week High
- PRLD $6.80
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- PRLD 51.42
- HYPR 42.83
- Support Level
- PRLD $0.77
- HYPR $0.53
- Resistance Level
- PRLD $1.00
- HYPR $0.67
- Average True Range (ATR)
- PRLD 0.11
- HYPR 0.05
- MACD
- PRLD -0.01
- HYPR 0.00
- Stochastic Oscillator
- PRLD 37.18
- HYPR 28.60
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.